JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Clorox (CLX) to $140 from $144 and keeps a Neutral rating on the shares as part of a quarterly earnings preview. The firm expects another challenging quarter for most names in the household and personal care sector.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox suing Cognizant, says hackers got passwords just by asking, Reuters says
- Clorox price target lowered to $134 from $150 at UBS
- Clorox price target lowered to $119 from $129 at Barclays
- Clorox price target lowered to $135 from $140 at Citi
- Clorox price target lowered to $135 from $142 at Wells Fargo